• Home
  • NEW DAY MEDICINE
  • 6 (38) 2021
  • 49 -6 (38) 2021 — Xodjiyeva D.T., Shodmanova S.K. — TO ACHIEVE THE GOAL OF THE STUDY AND TO SOLVE THE SET TASKS, GENERAL CLINICAL, LABORATORY AND INSTRUMENTAL RESEARCH METHODS WERE USED

49 -6 (38) 2021 — Xodjiyeva D.T., Shodmanova S.K. — TO ACHIEVE THE GOAL OF THE STUDY AND TO SOLVE THE SET TASKS, GENERAL CLINICAL, LABORATORY AND INSTRUMENTAL RESEARCH METHODS WERE USED

TO ACHIEVE THE GOAL OF THE STUDY AND TO SOLVE THE SET TASKS, GENERAL CLINICAL, LABORATORY AND INSTRUMENTAL RESEARCH METHODS WERE USED

Xodjiyeva D.T., Bukhara State Medical Institute

Shodmanova S.K. Bukhara State Medical Institute

Resume

Although the risk factors for ischemic stroke, the manifestations of cardio cerebral and cerebrocardial syndromes, have not been adequately studied, neurologists and cardiologists cannot describe the exact stage of the disease based on available diagnostic programs, our approach is to determine disease prognosis and evaluate its impact on treatment stages.

Keywords: Stroke, heart attack, atherosclerosis of the arteries, cerebrocardial syndrome, algorithm.

First page

280

Last page

285

For citation: Xodjiyeva D.T., Shodmanova S.K. TO ACHIEVE THE GOAL OF THE STUDY AND TO SOLVE THE SET TASKS, GENERAL CLINICAL, LABORATORY AND INSTRUMENTAL RESEARCH METHODS WERE USED //New Day in Medicine 6(38)2021 280-285 https://cutt.ly/zUW5A0a

LIST OF REFERENCES:

  1. Andersen K.K., Olsen T.S. Reduced poststroke mortality in patients with stroke and atrial fibrillation treated with anticoagulants. Results from a Danish quality-control registry of 22 179 patients with ischemic stroke // Stroke. – 2017. – Vol. 38. – P. 259-263.
  2. Shamalov N.A. Cryptogenic stroke / N.A. Shamalov, M.A. Kustova // Neurology, neuropsychiatry, psychosomatics. – 2014. – Special Issue 2. – pp. 42-49.
  3. Shandalin V.A., Fonyakin A.V., Geraskina L.A. Heart rate variability and cardiac disorders in the post-stroke period (prospective observation) // Materials of the X All-Russian Congress of Neurologists
  4. Adams H.P. et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment // Stroke. – 1993. – Vol. 24, № 1. – P. 35-41.
  5. Bots M.L. Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe // J. Epidemiol Community Health. – 2002. – Feb., vol. 56, suppl. 1114-1118.;
  6. Buono A, Gori T. No-reflow phenomenon in acute myocardial infarction: Relieve pressure from the procedure and focus attention to the patient. // Int J Cardiol Heart Vasc. -2019. – V.24. – P.: 104-117.
  7. Chartrain AG, Kellner CP, Mocco J. Pre-hospital detection of acute ischemic stroke secondary to emergent large vessel occlusion: lessons learned from electrocardiogram and acute myocardial infarction. // J Neurointerv Surg. 2018 Jun;10(6):549-553. doi: 10.1136/neurintsurg-2017-013428. Epub 2018 Jan 3. PMID: 29298860.
  8. Clinical Research Collaboration, Neurological Emergencies Treatment Trials Network, and the POINT Investigators. N Engl J Med. 2018 Jul 19; 379(3):215-225.
  9. Colivicchi F. et al. Cardiac autonomic derangement and arrhythmias in right-sided stroke with insular involvement // Stroke. – 2014. – Vol. 35, № 9. – P. 2094-2098.
  10. Elgendy IY, Mahmoud AN, Mansoor H, Mojadidi MK, Bavry AA. Evolution of acute ischemic stroke therapy from lysis to thrombectomy: Similar or different to acute myocardial infarction? // Int J Cardiol. 2016 Nov 1; 222: 441-447. doi: 10.1016/j.ijcard.2016.07.251. Epub 2016 Aug 1. PMID: 27505331.
  11. Firmann M. The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome // BMC. Cardiovasc. Disord. – 2008. – Vol. 17. – P. 8-16.
  12. George M.G., Tong X., Bowman B.A. Prevalence of Cardiovascular Risk Factors and Strokes in Younger Adults // JAMA Neurology. 2017. Vol. 74 (6). P. 695-703.
  13. Health 2020: the European policy for health and well-being. — WHO, World Health Report, 2020. — URL: httphttps://www.euro.who.int/en/about-us/regional-director/regional-directors-emeritus/dr-zsuzsanna-jakab,-2010-2019/health-2020-the-european-policy-for-health-and-well-being].
  14. Khadzhieva D.T., Khaydarov N.K. Khaydarova D.K. Correction of asthenoneurotic syndrome by the energy corrector cytoflavin // Neurology. – Tashkent, 2013. – No.3. Pp.16-19.,
  15. Khodzhieva D.T., Khaidarova D.K., Khaidarov N.K., Samadov A.U. Differentiated therapy in the acute period of ischemic stroke // Neurology – 2011. – No. 4. – p. 34.
  16. Kijpaisalratana N, Chutinet A, Suwanwela NC. Hyperacute Simultaneous Cardiocerebral Infarction: Rescuing the Brain or the Heart First? // Front Neurol. 2017 Dec 7; 8:664. doi: 10.3389/fneur.2017.00664. PMID: 29270151; PMCID: PMC5725403.

file

download